CLIA Waived 17 panel urine test FEN, NFYL, EDDP, PPX

17 Panel Urine Test Dip Card – CLIA Waived

When accuracy, speed, and regulatory compliance matter most, trust our CLIA Waived 17 Panel Urine Drug Test Dip Card to deliver exceptional results. This all-in-one diagnostic device is designed to detect the presence of 17 different drugs and their metabolites from a single urine sample—making it one of the most comprehensive dip tests on the market today.

Whether you’re conducting workplace drug screening, monitoring patients in recovery, or verifying compliance in legal or clinical settings, our 17 panel urine drug test offers peace of mind with reliable, lab-accurate results—fast.

Key Features

• Comprehensive Detection: Screens for 17 commonly abused drugs, offering a broad-spectrum analysis.

• Rapid Results: Delivers clear, easy-to-read results within 5 minutes.

• High Accuracy: Up to 99% accuracy rate, ensuring dependable outcomes.

• User-Friendly Design: Simple dip-and-read procedure requires no additional equipment.

• Compact and Portable: Lightweight design allows for easy storage and transport.

• Long Shelf Life: Up to 24 months, suitable for bulk purchasing and storage.

• CLIA Waived: Approved for use in various settings without the need for complex laboratory equipment

17 Panel Drug Test, Test For:

🛡️ Accuracy You Can Trust

Our 17 panel urine test dip cards are manufactured under strict quality controls and tested against interference from over-the-counter medications and food products. Their high specificity and sensitivity ensure false positives are rare and true positives are captured reliably.

Because this test is CLIA waived and FDA cleared, you can trust that it meets the highest standards in diagnostic reliability.

🔬 Who Uses the 17 Panel Urine Drug Test?

This test is used in a wide variety of applications:

• Hospitals and Clinics: For diagnostic aid and pain management monitoring.

• Substance Abuse Treatment Centers: To ensure compliance with program policies.

• Human Resource Departments: For pre-employment and random workplace testing.

• Probation/Parole Officers: To confirm adherence to court-mandated sobriety.

• Rehabilitation Facilities: To track ongoing patient progress.

• Parents and Schools: To discreetly screen for substance exposure.

The test’s wide panel of drugs—including Fentanyl, Norfentanyl, Methadone Metabolite (EDDP), and synthetic cannabinoids—makes it ideal for detecting newer drug threats along with traditional substances.

✅ CLIA Waived for Versatile Use

This test is CLIA waived, which means it is approved for use in environments with a lower complexity of laboratory oversight. It is ideal for:

• Clinical settings

• Hospitals and urgent care

• Workplace drug testing

• Addiction recovery programs

• Probation and legal compliance monitoring

• School and athletic testing programs

The 17 panel test offers laboratory-level reliability without requiring specialized equipment or training.

📦 Product Specifications

• Product Type: 17 Panel Drug Test Dip Card

• Test Method: Lateral flow immunoassay

• Results Time: 5 minutes

• Specimen Type: Urine

• Certifications: CLIA Waived, FDA Cleared (510k)

• Shelf Life: 24 months from manufacturing date

• Storage Conditions: 36°F–78°F (2°C–25°C), away from moisture and sunlight

• Packaging: Individually foil wrapped

🧠 Why Choose a Dip Card Over a Test Cup?

Though both provide highly accurate results, a dip card offers added flexibility in certain situations:

Choose the dip card when you’re looking for lower per-unit cost, space-saving storage, and flexibility in sample handling.

⚠️ Important Notes

• Preliminary Results Only: A positive result from this test is preliminary. Confirm with GC/MS or LC/MS in a certified lab.

• In Vitro Use Only: Not for internal use or diagnostic procedures inside the body.

• Do Not Freeze: Store at room temperature only.